FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone to Treat Complex Regional Pain Syndrome
The FDA recently granted the pharmaceutical company Soin Therapeutics, based in Dayton, OH, orphan drug status for low dose naltrexone (LDN) to treat complex regional...